Phase Forward to Present at 45th DIA Annual Meeting, June 21-25, San Diego
WALTHAM, Mass.–(BUSINESS WIRE)–Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will drive nine key sessions at the 45th Annual Meeting of the Drug Information Association (DIA), to be held June 21-25 in San Diego, California.
Company representatives will address the benefits and challenges inherent in leveraging technology for global clinical trials – from planning a mega trial to managing the audit process. Full session details are as follows:
|
WHO: |
Andrea Bradbury, Vice President, Compliance and Quality, Clarix Products Group, Phase Forward (Panelist) | ||
|
WHAT: |
“Quality Assurance Perspective on XP in a Regulated Industry” | ||
|
WHEN: |
Monday, June 22, 1:30-3:00 p.m. | ||
|
WHO: |
Joel Hoffman, Ph.D., M.A., Senior Director, Phase Forward Waban Software Group (Session Chair) | ||
|
WHAT: |
“Clinical Trial Metadata: Theory into Practice” | ||
|
WHEN: |
Tuesday, June 23, 2:00-3:30 p.m. | ||
|
WHO: |
Tim Rochford, Chief Technical Officer, Phase Forward (Session Chair) | ||
|
WHAT: |
“Clinical Research Repositories as a Collaboration Platform” | ||
|
WHEN: |
Wednesday, June 24, 8:30-10:00 a.m. | ||
|
WHO: |
Sally Cassells, M.S., Vice President, Phase Forward Lincoln Safety Group (Session Chair) | ||
|
WHAT: |
“Deploying XML Technology at the FDA” | ||
|
WHEN: |
Wednesday, June 24, 8:30-10:00 a.m. | ||
|
WHO: |
Michael Owings, Vice President, Quality and Regulatory Compliance, Phase Forward (Panelist) | ||
|
WHAT: |
“Managing the QA Audit Process for GCP Compliance: Successes and Challenges” | ||
|
WHEN: |
Wednesday, June 24, 1:30-3:00 p.m. | ||
|
WHO: |
Wayne R. Kubick, MBA, Vice President and Chief Quality Officer, Phase Forward Lincoln Safety Group (Panelist) | ||
|
WHAT: |
“Validation and Uses of Standardized Submission Data: Evolving Perspectives” |
||
|
WHEN: |
Wednesday, June 24, 3:30-5:00 p.m. | ||
|
WHO: |
Patrick J. Burns, MHA, M.S., Project Manager, Phase Forward (Session Chair) | ||
|
WHAT: |
“Mega Trials: Planning, Design, Development, Monitoring and Overall Management” |
||
|
WHEN: |
Wednesday, June 24, 3:30-5:00 p.m. | ||
|
WHO: |
Tim Rochford, Chief Technical Officer, Phase Forward (Panelist) | ||
|
WHAT: |
“Electronic Health Records in Clinical Research: The Time is Now” | ||
|
WHEN: |
Wednesday, June 24, 3:30-5:00 p.m. | ||
|
WHO: |
Wayne R. Kubick, MBA, Vice President and Chief Quality Officer, Phase Forward Lincoln Safety Group (Session Chair) |
|
|
|
WHAT: |
“Standards Shock Therapy: Monitoring the State of CDISC and HL7 for Clinical Research and Regulatory Submissions” |
||
|
WHEN: |
Thursday, June 25, 10:30 a.m.-12:00 p.m. | ||
In booth #729, Phase Forward will showcase its solutions for electronic data capture (EDC) and drug safety data management; phase I clinic automation; Web-integrated interactive response technology (IRT); and clinical data analysis and reporting automation and compliance.
Members of the media interested in speaking with Phase Forward at the event should contact Meghan Locke at CHEN PR at 781-672-3147 or mlocke@chenpr.com.
For additional conference information and session details, please click here.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (Empirica Signal™) and Signal Management, adverse event reporting (Empirica Trace™), applied data standards (WebSDM™), Web-integrated interactive response technologies (Clarix™), and clinical data analysis and reporting automation and compliance (Waban SCE/CDR, Waban SMS and Waban LIMS). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
